BIO-Europe Spring 2019: Amphera Develops Autologous Dendritic Cell Therapy For Cancer
Executive Summary
Rob Meijer, CEO of Amphera, explains the company’s dendritic cell therapies and its approach to turning “cold” tumors “hot” to render them amenable to treatment by immunotherapy.